```html

Kuiper Disease (X‑Linked Ichthyosis)

Overview

Kuiper disease, more commonly known as X‑linked ichthyosis (XLI), is a genetic skin disorder characterized by dry, scaly skin that appears shortly after birth. The condition follows an X‑linked recessive inheritance pattern, meaning the defective gene is located on the X chromosome. Because males have only one X chromosome, they manifest the disease when they inherit the mutant gene. Females can be carriers and may show very mild skin changes, but they rarely develop the full‑blown phenotype.

Who it affects

• Primarily males (≈1 in 2,000–6,000 live births worldwide).
• Female carriers occur in roughly 1 in 1,500–3,000 births; they may have subtle scaling.

Prevalence

Data from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) estimate a prevalence of 1 per 2,000–6,000 male births in the United States and Europe, with slightly higher rates reported in regions where consanguineous marriages are common [1][2].

Symptoms

The clinical picture of X‑linked ichthyosis is relatively consistent, but severity can vary. The main features are:

Skin Findings

• Polygonal, dark brown or gray scales on the trunk, extensor surfaces of the arms and legs, and the neck. Scales are usually larger than those seen in autosomal recessive ichthyosis.
• Absence of erythema – unlike other forms of ichthyosis, the skin is not inflamed.
• Fine, adherent crusting after heat exposure or sweating.
• Hyperlinear palmoplantar keratoderma (thickening of the skin on the palms and soles) in up to 30 % of patients.

Associated Non‑Dermatologic Features

• Corneal opacity (rare, 1–2 % of cases) leading to mild visual disturbance.
• Cryptorchidism (undescended testes) – reported in 2–5 % of males with XLI.
• Mild developmental or learning difficulties in a small subset; the link may be due to concurrent deletions of neighboring genes (e.g., STS‑containing microdeletions).
• Cardiovascular anomalies (e.g., atrial septal defects) noted in some patients with larger chromosomal deletions.

Onset & Course

Scales are typically evident within the first few weeks of life, become most prominent between ages 5–15, and may lessen slightly in adulthood. However, the condition is chronic and lifelong.

Causes and Risk Factors

X‑linked ichthyosis is caused by a deficiency of the enzyme steroid sulfatase (STS)**, which is encoded by the STS gene on chromosome Xp22.31. The enzyme normally removes sulfate groups from steroid sulfates, a step important for skin barrier formation.

Genetic Mechanisms

• Gene deletions – The most common mutation is a deletion of the entire STS gene (~90 % of cases).
• Point mutations – Small insertions, deletions, or missense changes account for the remaining cases.
• Contiguous gene deletions – Larger deletions that include neighboring genes can lead to additional findings (e.g., Kallmann syndrome, intellectual disability).

Inheritance & Risk

• Carrier mother has a 50 % chance of passing the mutant X chromosome to each son (who will be affected) and a 50 % chance of making each daughter a carrier.
• Affected fathers cannot pass XLI to sons (they give a Y chromosome), but all daughters become carriers.
• Consanguinity or a family history of XLI increases risk.

Environmental Triggers

While the genetic defect is the primary cause, certain factors can exacerbate scaling:

• Low humidity or cold climates.
• Excessive heat and sweating.
• Harsh soaps, detergents, or abrasive fabrics.

Diagnosis

Diagnosis is clinical, supported by laboratory and genetic testing.

Clinical Evaluation

• Physical examination focusing on the characteristic scaling pattern.
• Family history to identify X‑linked inheritance.

Laboratory & Genetic Tests

• Steroid sulfatase activity assay – Measured in blood leukocytes or cultured fibroblasts; markedly reduced activity confirms the diagnosis.
• Fluorescence in situ hybridization (FISH) or MLPA (multiplex ligation‑dependent probe amplification) – Detects deletions of the STS gene.
• Sequencing – Identifies point mutations when deletion testing is negative.

Additional Work‑up

• Ophthalmologic exam if corneal involvement is suspected.
• Ultrasound of the abdomen/pelvis in newborn boys to rule out undescended testes.
• Genetic counseling for families planning future pregnancies.

Treatment Options

There is no cure, but treatment focuses on improving the skin barrier, reducing scaling, and managing associated problems.

Topical Therapies

• Keratolytic agents – 5–10 % salicylic acid, 12 % lactic acid, or urea creams (10–20 %) soften scales.
• Emollients – Thick, fragrance‑free moisturizers applied several times daily to maintain hydration (e.g., petrolatum, ceramide‑containing creams).
• Topical retinoids (tazarotene 0.05 %) can be used for resistant plaques but may cause irritation; start with low frequency.

Systemic Treatments

• Oral **retinoids** (acitretin 0.5–1 mg/kg/day) are effective for severe cases, reducing scale formation